期刊
TRENDS IN PHARMACOLOGICAL SCIENCES
卷 37, 期 9, 页码 768-778出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2016.06.007
关键词
-
资金
- National Institutes for Health [NIH R01NS39587, NIH RO1NS086423, UO1NS083422]
There is widespread recognition that reactive oxygen species (ROS) play key roles in normal brain function and pathology in the context of neurological disease. Oxidative stress continues to be a key therapeutic target for neurological diseases. In developing antioxidant therapies for neurological disease, special attention should be given to the brain's unique vulnerability to oxidative insults and its architecture. Consideration of antioxidant therapy should be guided by a strong rationale for oxidative stress in a given neurological disease. This review provides an overview of processes that can guide the development of antioxidant therapies in neurological diseases, such as knowledge of basic redox mechanisms, unique features of brain pathophysiology, mechanisms and classes of antioxidants, and desirable properties of drug candidates.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据